CONMED
CNMD
160 hedge funds and large institutions have $1.42B invested in CONMED in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 9 closing their positions.
508% more call options, than puts
Call options by funds: $681K | Put options by funds: $112K
178% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 9
11% more funds holding
Funds holding: 144 → 160 (+16)
10% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 50
0.87% less ownership
Funds ownership: 100.58% → 99.72% (-0.87%)
4% less capital invested
Capital invested by funds: $1.47B → $1.42B (-$53.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$9.98M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$5.94M |
| 3 |
Millennium Management
New York
|
+$5.88M |
| 4 |
BlackRock
New York
|
+$4.43M |
| 5 |
JP Morgan Chase
New York
|
+$3.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$24.2M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$9.52M |
| 3 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$8.71M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.21M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$4.28M |
CNMD Hedge Fund Activity: Q4 2017 in Review
160 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q4 2017, worth a combined $1.42B — down 3.6% from $1.47B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new CNMD positions and 9 closed out — a net gain of 16 holders — while 55 added to existing stakes and 50 trimmed.
The largest buyer was State Street, adding an estimated $9.98M. The largest seller was Capital World Investors, cutting an estimated $24.2M.
- 160 institutional investors held CONMED (CNMD) as of Q4 2017, up from 144 in Q3 2017.
- Funds reported $1.42B of CONMED stock for Q4 2017, down 3.6% quarter-over-quarter.
- 25 funds opened new CONMED positions in Q4 2017 and 9 closed out, a net change of +16 holders.
- The largest CONMED buyer in Q4 2017 was State Street, an estimated $9.98M added.
- The largest CONMED seller in Q4 2017 was Capital World Investors, an estimated $24.2M sold.
Based on aggregated 13F filings for Q4 2017.